Correlation Between Mineralys Therapeutics, and Revolution Medicines

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Revolution Medicines, you can compare the effects of market volatilities on Mineralys Therapeutics, and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Revolution Medicines.

Diversification Opportunities for Mineralys Therapeutics, and Revolution Medicines

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Mineralys and Revolution is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Revolution Medicines go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Revolution Medicines

Given the investment horizon of 90 days Mineralys Therapeutics, is expected to generate 19.32 times less return on investment than Revolution Medicines. In addition to that, Mineralys Therapeutics, is 1.09 times more volatile than Revolution Medicines. It trades about 0.0 of its total potential returns per unit of risk. Revolution Medicines is currently generating about 0.08 per unit of volatility. If you would invest  2,444  in Revolution Medicines on August 29, 2024 and sell it today you would earn a total of  3,419  from holding Revolution Medicines or generate 139.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Mineralys Therapeutics, Common  vs.  Revolution Medicines

 Performance 
       Timeline  
Mineralys Therapeutics, 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Mineralys Therapeutics, is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Revolution Medicines 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Revolution Medicines are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating primary indicators, Revolution Medicines exhibited solid returns over the last few months and may actually be approaching a breakup point.

Mineralys Therapeutics, and Revolution Medicines Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mineralys Therapeutics, and Revolution Medicines

The main advantage of trading using opposite Mineralys Therapeutics, and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.
The idea behind Mineralys Therapeutics, Common and Revolution Medicines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets